Dupilumab in CRSsNP

PHASE3CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

November 14, 2023

Study Completion Date

January 29, 2024

Conditions
Chronic Rhinosinusitis Without Nasal PolypsSinusitisChronic SinusitisSinus DisorderRespiratory Disorder
Interventions
DRUG

Dupilumab SAR231893

Pharmaceutical form:Injection solution Route of administration: Subcutaneous

DRUG

Placebo

Pharmaceutical form:Injection solution Route of administration: Subcutaneous

Trial Locations (58)

1115

Investigational Site Number : 3480004, Budapest

3000

Investigational Site Number : 0560001, Leuven

7621

Investigational Site Number : 3480001, Pécs

9000

Investigational Site Number : 0560002, Ghent

11407

Investigational Site Number : 7240004, Jerez de la Frontera

23507

Eastern Virginia Medical School (EVMS) Medical Group - Otola Site Number : 8400009, Norfolk

28027

Investigational Site Number : 7240009, Madrid

28034

Investigational Site Number : 7240010, Madrid

28040

Investigational Site Number : 7240005, Madrid / Madrid

31008

Investigational Site Number : 7240008, Pamplona

39008

Investigational Site Number : 7240007, Santander

41009

Investigational Site Number : 7240002, Seville

43235

Optimed Research, LTD Site Number : 8400017, Columbus

49006

Investigational Site Number : 8040005, Dnipro

61166

Investigational Site Number : 8040004, Kharkiv

65212

University of Missouri Health System Site Number : 8400016, Columbia

68046

Nebraska Medical Research Institute Site Number : 8400007, Papillion

74136

Vital Prospects Clinical Research Institute, P.C. Site Number : 8400004, Tulsa

74137

Essential Medical Research, LLC Site Number : 8400014, Tulsa

75231

Pharmaceutical Research & Consulting, Inc. Site Number : 8400006, Dallas

76018

Investigational Site Number : 8040001, Ivano-Frankivsk

78258

Alamo ENT Associates Site Number : 8400021, San Antonio

80230

Colorado Allergy and Asthma Centers, PC Site Number : 8400003, Denver

95207

Bensch Clinical Research LLC Site Number : 8400015, Stockton

95661

Sacramento Ear, Nose & Throat Site Number : 8400010, Roseville

100730

Investigational Site Number : 1560001, Beijing

121359

Investigational Site Number : 6430005, Moscow

130021

Investigational Site Number : 1560005, Changchun

197022

Investigational Site Number : 6430002, Saint Petersburg

Investigational Site Number : 6430003, Saint Petersburg

200065

Investigational Site Number : 1560006, Shanghai

264000

Investigational Site Number : 1560008, Yantai

355020

Investigational Site Number : 6430001, Stavropol

400016

Investigational Site Number : 1560010, Chongqing

410013

Investigational Site Number : 1560013, Changsha

8207257

Investigational Site Number : 1520001, Santiago

C1121ABE

Investigational Site Number : 0320002, Buenos Aires

C1414AIF

Investigational Site Number : 0320003, Ciudad Autonoma Buenos Aires

C1425BEN

Investigational Site Number : 0320001, Ciudad Autonoma Buenos Aires

V6Z 1Y6

Investigational Site Number : 1240013, Vancouver

L8L 2X2

Investigational Site Number : 1240010, Hamilton

K7L 2V7

Investigational Site Number : 1240007, Kingston

N6A 4V2

Investigational Site Number : 1240016, London

H2X 3E4

Investigational Site Number : 1240001, Montreal

H4A 3J1

Investigational Site Number : 1240012, Montreal

G8T 7A1

Investigational Site Number : 1240002, Trois-Rivières

G1V 4G5

Investigational Site Number : 1240005, Québec

G1V 4W2

Investigational Site Number : 1240003, Québec

3810-501

Investigational Site Number : 6200002, Aveiro

4810-061

Investigational Site Number : 6200001, Guimarães

4464-513

Investigational Site Number : 6200003, Matosinhos Municipality

07061

Investigational Site Number : 4100003, Seoul

135-710

Investigational Site Number : 4100002, Seoul

08036

Investigational Site Number : 7240001, Barcelona

171 76

Investigational Site Number : 7520001, Stockholm

01033

Investigational Site Number : 8040008, Kyiv

03680

Investigational Site Number : 8040002, Kyiv

04050

Investigational Site Number : 8040007, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY

NCT04678856 - Dupilumab in CRSsNP | Biotech Hunter | Biotech Hunter